Prof. Dr. Dominik Fleischmann

08/2021

Prof. Dr. Dominik Fleischmann

Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.

Related Resources

Leave No Data Behind: Commitment to Data Excellence

05/2025

At Mint Medical, we understand data as a cornerstone for improving patient care and groundbreaking research. Our mission is clear: Leave No Data…

Central Imaging Review Analysis with mint Lesion - read-ready in minutes, not weeks

05/2025

Watch in the video above a demonstration of our central imaging review software featuring a pre-configured, master trial workflow database designed to…

ESOI-EORTC Workshop 2025

05/22 to 05/24/2025 Brussels, Belgium

Hands-on course: Imaging in Assessing Response to Cancer Therapy

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	Used to store a few details about the user such as the unique visitor ID.	13 months	HTML	Matomo
_pk_ref	Used to store the attribution information, the referrer initially used to visit the website.	6 months	HTML	Matomo
_pk_ses	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_cvar	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_hsr	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo

The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.